Their suggestion of a causal role of POLE mutations in the constitution of an ultramutator phenotype CRC was backed by previous observations in mice being homozygous for a mutation in POLE that inactivates exonuclease activity. This evidence concerns the gene POLE and colorectal carcinoma.